SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,160 | -59.4% | 6,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $5,316 | -75.8% | 6,000 | -57.1% | 0.00% | -80.0% |
| Q3 2022 | $22,000 | -21.4% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $28,000 | -15.2% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $33,000 | +17.9% | 14,000 | +133.3% | 0.01% | +25.0% |
| Q4 2021 | $28,000 | -68.2% | 6,000 | -47.8% | 0.00% | -71.4% |
| Q3 2021 | $88,000 | -9.3% | 11,500 | +15.0% | 0.01% | -12.5% |
| Q2 2021 | $97,000 | +4.3% | 10,000 | -11.0% | 0.02% | -5.9% |
| Q1 2021 | $93,000 | +12.0% | 11,230 | -8.2% | 0.02% | +6.2% |
| Q4 2020 | $83,000 | -38.1% | 12,230 | +1.9% | 0.02% | -44.8% |
| Q3 2020 | $134,000 | +78.7% | 12,000 | 0.0% | 0.03% | +70.6% |
| Q2 2020 | $75,000 | +400.0% | 12,000 | +50.0% | 0.02% | +325.0% |
| Q1 2020 | $15,000 | +200.0% | 8,000 | +433.3% | 0.00% | +300.0% |
| Q4 2019 | $5,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |